Thyroid

Papers
(The H4-Index of Thyroid is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-04-01 to 2026-04-01.)
ArticleCitations
The Epidemiology of Thyroid Eye Disease in Olmsted County, Minnesota, 2005–2020253
Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-Analysis Examining Prevalence, Follow-Up, and Risk of Malignancy230
A Comprehensive Review of Thyroid Hormone Metabolism in the Gut and Its Clinical Implications229
International Women’s Day: An Occasion for a Tribute to Women Leaders in the American Thyroid Association168
Letter to the Editor: ETV6-NTRK2 Fusion Identified in a Patient with Medullary Thyroid Carcinoma120
Maternal Exercise Before and During Pregnancy Facilitates Embryonic Myogenesis by Enhancing Thyroid Hormone Signaling98
A Novel Levothyroxine Solution Results in Similar Bioavailability Whether Taken 30 or Just 15 Minutes Before a High-Fat High-Calorie Meal93
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Thyroid90
Development and Progression of Thyroid Disease in PTEN Hamartoma Tumor Syndrome: Refined Surveillance Recommendations85
35th Anniversary of Thyroid—Journal of the American Thyroid Association81
Effects of Triiodothyronine Treatment in an Animal Model of Heart Failure with Preserved Ejection Fraction73
Molecular and Clinical Features of Congenital Hypothyroidism Due to Multiple DUOX2 Variants72
Minimally Invasive Ablative Treatments for Benign Thyroid Nodules: Current Evidence and Future Directions68
Future Meetings68
Investigating Levothyroxine Use and Its Association with Thyroid Health in Patients with Hypothyroidism: A Community Pharmacy Study66
Stage-Dependent Death Hazard and Conditional Survival of Patients with Papillary Thyroid Cancer64
Geraldo A. de Medeiros-Neto, MD, MACP (June 5, 1935–January 21, 2022)64
Role of Thyrotropin-Releasing Hormone in Regulating Fibroblast Growth Factor 21 in Mouse Pancreatic β Cells61
A Multicenter, Single-Blind, Case-Control, Immunohistochemical Study of Orbital Tissue in Thyroid Eye Disease57
Re: “Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status” by Yamamoto et al.54
Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up52
A Conversation with Samuel Refetoff, MD: How Treating One Family Stimulated a Lifelong Series of Major Discoveries in Thyroid Physiology and Disease48
The Scientific Contributions of Martin Surks, MD, MACP: A Pioneer in Thyroid Hormone Physiology, Subclinical Hypothyroidism, and Endocrine Education48
A Cross-Sectional Survey of Patient Treatment Choice in a Multicenter Prospective Cohort Study on Active Surveillance of Papillary Thyroid Microcarcinoma (MAeSTro)46
Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis46
Regular Call Oral Abstracts44
Remote-Access Thyroidectomy and Parathyroidectomy: A 2025 Consensus Statement from the Asia-Pacific Society of Thyroid Surgery, American Head and Neck Society, American Association of Endocrine Surgeo42
Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma40
Preliminary Evidence of Potential Association Between Exposure to Estriol-Containing Skincare Cosmetics Sold in China and Autoimmune Thyroid Disease39
Abstract Author Index38
The Year in Thyroidology: Surgical Science38
The American Thyroid Association 1923–2023: Honoring Our Past, Embracing Our Future38
Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers38
The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study36
Delayed Thyrotropin Rise in Preterm Newborns: Value of Multiple Screening Samples and of a Detailed Clinical Characterization36
A Case Report of Poor Response to Selpercatinib in the Presence of a 632_633 RET Deletion35
Letter to the Editor: Remission of Graves' Disease After Initiation of Ocrelizumab in Patients with Multiple Sclerosis35
Correction to: The Diagnostic Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Differe35
0.88398003578186